| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $5.4M | -14.9% |
| SG&A Expense | $3.1M | +20.7% |
| Operating Income | -$8.5M | +4.8% |
| Interest Expense | $50K | +5210.0% |
| Net Income | -$8.3M | +3.4% |
| EPS (Basic) | -$0.70 | +5.4% |
| EPS (Diluted) | -$0.70 | +5.4% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -41.1% |
| Current Assets | $5.0M | -41.1% |
| Total Assets | $12.8M | -24.1% |
| Current Liabilities | $1.4M | +154.3% |
| Total Liabilities | $1.4M | -33.2% |
| Stockholders' Equity | $11.5M | -22.9% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | -11.4% |
| Capital Expenditures | $157K | +3.2% |
| Investing Cash Flow | -$157K | -3.2% |
| Financing Cash Flow | $3.1M | +3391.6% |
| Free Cash Flow | -$6.5M | -11.2% |